期刊文献+

敲低miR-19a、miR-19b抑制人脑胶质瘤细胞生长的体外研究 被引量:5

Inhibitory effects of knocking down microRNA-19a and microRNA-19b on glioma cell growth invitro
原文传递
导出
摘要 目的探究敲低microRNA(miR).19a和miR-19b表达对人脑胶质瘤细胞系SNB19细胞生物学特征的影响。方法常规培养SNB19细胞,脂质体介导miR-19a、miR-19b抑制物转染SNB19细胞,同时设未转染组(对照组1、无义序列转染组和miR-19a+miR-19b抑制物转染组。应用RT.PCR检测转染后细胞miR-19a、miR-19b的表达,MTT、流式细胞术分别检测转染后细胞增殖能力和细胞周期的变化,Transwell实验检测转染后细胞的侵袭能力。结果与对照组和无义序列转染组比较,抑制物转染组细胞miR-19a和miR-19b的表达、增殖和侵袭能力均降低,差异有统计学意义(P〈O.05),而且miR-19a+miR-19b抑制物转染组细胞miR.19a和miR-19b的表达、转染后2、3、4、5d细胞的增殖能力、侵袭能力均低于miR-19a、miR-19b抑制物转染组.差异有统计学意义(JD〈0.05);抑制物转染组较对照组和无义序列转染组细胞周期延迟,且miR-19a+miR-19b抑制物转染组较miR-19a、miR-19b抑制物单独转染组细胞延迟更为明显。结论miR-19a和miR-19b可能是癌微RNA.有望作为人脑胶质瘤基因治疗的侯选靶点。 objective To investigate the effects of knocking down ofmiR-19a and miR-19b on the biological characteristics of SNB19 glioblastoma cells. Methods Oligonucleotides inhibitor of miR-19a and miR-19b (miR-19a inhibitor or miR-19b inhibitor) mediated by lipofectamine2000 were transfected to SNB19 cells to knock down miR-19a and miR-19b; control group (without transfection), group D (performing transfection with nonsense sequence) and group E (performing transfection with both miR-19a inhibitor and miR-19b inhibitor) were established. Real time PCR was conducted to detect the expressions ofmiR-19a and miR-19b in these groups after the transfection. The cell proliferation rate and cell cycle kinetics were detected by 3-(4, 5-Dime- -thylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay and flow cytometry, respectively; the cell invasive ability was evaluated by Transwell assay. Results As compared with those in control group and group D, the expressions of miR-19a and miR-19b, proliferation activity and invasive ability of cells in the miR-19a/19b inhibitor transfected cells (group A/B) were significantly reduced (P〈0.05). The expressions of miR-19a and miR-19b and the proliferation activity and invasive ability of cells 2, 3, 4 and 5 d after the transfection in group E were significantly reduced as compared with those in group A/B (P〈0.05). Delayed cell cycle in group A/B and group E was noted as compared with that in control group and group D; and group E enjoyed more obviously delayed cell cycle than group A/B (P〈0.05). Conclusion MiR-19a and miR-19b might be oncomiRs, and may be candidate target miRNAs for gene therapy of glioma.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第4期365-368,共4页 Chinese Journal of Neuromedicine
关键词 RANS 神经胶质瘤 细胞增殖 侵袭 Micro RANs Glioma Proliferation Invasion
  • 相关文献

参考文献14

  • 1Meister G,Tuschl T.Mechanisms of gene silencing by double stranded RNA[J].Nature,2004,431(7006):343-349.
  • 2Tijsterman M,Plasterk RH.Dicers at RISC; the mechanism of RNAi[J].Cell,2004,117(1):1-3.
  • 3Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)Method[J].Methods,2001,25(4):402-408.
  • 4韩磊,张安玲,岳晓,杨旸,王广秀,贾志凡,浦佩玉,康春生.RNA干扰联合抑制PI3KP85和AKT1表达对U251胶质瘤细胞侵袭的影响[J].中华神经医学杂志,2010,9(6):566-570. 被引量:7
  • 5曹丽芝,龙明辉,陈金燕,刘人树.MTT法对恶性淋巴瘤的药敏检测及临床应用研究[J].实用医学杂志,2010,26(20):3743-3745. 被引量:4
  • 6Calin GA,Sevignani C,Dumitru CD,et al.Human microRNA genes are frequently located at fragile site and genomic regions involved in cancers[J].Proc Natl Acad Sci USA,2004,101(9):2999-3004.
  • 7Calin GA,Dumitru CD,Shimizu M,et al.Frequently deletions and down-regulation ofmicroRNA genes miR-15 and miR-16 at 13q14 in chronic lymphocytic leukemia[J].Proc Natl Acad Sci USA,2002,99(24):15524-15529.
  • 8Ota A,Tagawa H,Karnan S,et al.Identification and characterization of a novel gene,C13 or f25,as a target for 13q31-q32 amplification in malignant lymphoma[J].Cancer Res,2004,64(9):3087-3095.
  • 9Calin GA,Liu CG,Sevignani C,et al.MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias[J].Proc Natl Acad Sci USA,2004,101(32):11755-11760.
  • 10Pezzolesi MG,Platzer P,Waite KA,et al.Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome[J].Am J Hum Genet,2008,82(5):1141-1149.

二级参考文献21

  • 1勇威本.恶性淋巴瘤药物治疗的进展[J].中国处方药,2002,1(7):29-32. 被引量:2
  • 2贾志凡,浦佩玉,康春生,王广秀,张志勇,裘明哲,江荣才.星形细胞肿瘤SEPT 7/hCDC10的表达研究[J].中华神经外科杂志,2006,22(10):636-639. 被引量:10
  • 3Cully M,You H,Levine Al,et al.Beyond PTEN mutations:the PI3K pathway as an integrator of multiple inputs during tumorigenesis[J].Nat Rev Cancer,2006,6(3):184-192.
  • 4Bernstein E,Candy AA,Hammond SM,et al.Role for a bidentate ribonuclease in the initiation step of RNA interference[J].Nature,2001,409(6818):363-366.
  • 5Sui G,Soohoo C,Affar EIB,et al.A DNA vector based RNAi technology to suppress gene expression in mammalian cells[J].PNAS,2002,99(8):5515-5520.
  • 6Richard CM.The basic science of gene therapy[J].Science,1993,260(5110):926-932.
  • 7Cully M,You H,Levine A J,et al.Beyond PTEN mutations:the PI3K pathway as an integrator of multiple inputs during tumorigenesis[J].Nat Rev Cancer,2006,6(3):184-192.
  • 8Kwon M J,Nam TJ.A polysaccharide of the marine alga Capsosiphon fuivescans induces apoptosis in AGS gastric cancer cells via an IGF-IR-mediated PI3K/Akt pathway[J].Cell Biol Int,2007,31 (8):768-775.
  • 9Dey JH,Bianchi F,Voshol J,et al.Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling,induces apoptosis,and impairs mammary rumor outgrowth and metastasis[J].Cancer Res,2010,70(10):4151-4162.
  • 10Liang J,Pan Y,Zhang D,et al.Cellular priori protein promotes proliferation and GI/S transition of human gastric cancer cells SGC7901 and AGS[J].FASEB J,2007,21(9):2247-2256.

共引文献17

同被引文献35

  • 1易伟,叶飞,郭东升,薛德麟,雷霆.LRIG1基因在人星形细胞瘤中的表达下调与意义[J].中华实验外科杂志,2005,22(6):759-759. 被引量:11
  • 2贾志凡,浦佩玉,康春生,王广秀,张志勇,裘明哲,江荣才.星形细胞肿瘤SEPT 7/hCDC10的表达研究[J].中华神经外科杂志,2006,22(10):636-639. 被引量:10
  • 3康春生,浦佩玉,贾志凡,张志勇,王广秀,刘晓智,裘明哲.反义AKT2 RNA抑制U251胶质瘤细胞生长的体内外研究[J].中华神经医学杂志,2007,6(2):113-117. 被引量:7
  • 4贾志凡,浦佩玉,康春生,王广秀,张志勇,裘明哲,黄强.SEPT7对胶质瘤细胞系TJ905生物学特性的影响[J].中华外科杂志,2007,45(20):1420-1423. 被引量:9
  • 5Ciafre SA, Galardi S, Mangiola A ,et al. Extensive modulation of a setof microRNAs in primary glioblastoma [ J ]. Biochem Biophys ResCommun,2005,334(4) :1351-1358.
  • 6Malzkom B,Wolter M,Liesenberg F,et al. Identification and function-al characterization of microRNAs involved in the malignant progres-sion of gliomas[ J]. Brain Pathol,2010,20(3) :539-550.
  • 7Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and func-tion[J]. Cell,2004,116(2) :281-297.
  • 8Olive V, Bennett MJ, Walker JC, et al. MiR-19 is a key oncogeniccomponent of mir-17-92[ J] . Genes Dev ,2009,23 (24) ;2839-2849.
  • 9Zhang X,Yu H,Lou JR,et al. MicroRNA-19 (miR-19) regulates tis-sue factor expression in breast cancer cells [ J]. J Biol Chem,2011,286(2) :1429-1435.
  • 10Xu XM,Wang XB,Chen MM,et al. MicroRNA-19a and~19b regulatecervical carcinoma cell proliferation and invasion by targeting CUL5[J]. Cancer Lett,2012,322(2) : 148-158.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部